ArticleDermatology practical & conceptual2025

Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series.

Fabio Artosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.